Issue No. 07 · 2026

Scar Tissue and
Autologous Fat Grafting

Autologous fat grafting as an approach studied in scars — evidence from 26 clinical studies, 905 patients · Negenborn VL et al., Plast Reconstr Surg. 2016
Executive Summary

Negenborn et al. (2016) conducted a systematic review of MEDLINE, Cochrane Library, EMBASE, and Web of Science, including 26 clinical studies involving 905 patients who underwent autologous fat grafting for application in scar tissue.

Key finding: ALL 26 studies reported a beneficial effect on scar tissue. Five studies documented statistically significant improvements in appearance, skin characteristics, and pain.

IMPORTANT LIMITATION: the level of evidence was predominantly low to intermediate (level III/IV on the Oxford OCEBM scale). Randomized controlled trials with greater methodological rigor are still needed.

26
clinical studies included
905
patients
100%
of studies reported a benefit
63%
retention with SVF vs. 39% without SVF (Gentile 2014)
01

Methodology — Scope and Criteria

TypePRISMA systematic review. Databases: MEDLINE, Cochrane, EMBASE, Web of Science. No language restrictions.
PeriodStudies published between January 2004 and August 2014.
InclusionRCTs, prospective and retrospective cohorts, case-control studies. Criteria: ≥5 patients, follow-up ≥6 months.
Screening results17,956 articles screened by title → 26 studies included, 905 patients.
Levels of evidenceLevel II: 5 studies (4 RCTs). Level III: 7 studies. Level IV: 14 studies.
Statistical analysisMeta-analysis NOT performed — methodological heterogeneity. Narrative synthesis.
02

The Four Outcomes Evaluated

2.1 Appearance and Skin Characteristics (6 studies, 190 patients)

  • Significant improvement in dermal elasticity in 14 patients (Sardesai & Moore, 2007)
  • Significant improvement in scar stiffness and thickness in 38 patients (Klinger et al. 2013)
  • 156 patients reported overall satisfaction, confirmed by a surgeon or independent observer

2.2 Volume and Contour Restoration (13 studies, 357 patients)

31%
retention — AFG alone (Coleman)
63%
retention — SVF-enhanced (Gentile 2014)
70–90%
retention — AFG + PRP ± insulin
🔬 Critical Finding for LipAge

Adding stromal vascular fraction (SVF) to the autologous fat graft increased volume retention from 39% to 63% in a prospective comparative study (Gentile et al. 2014). This directly supports the argument for the quality of cryopreserved material — the presence of ASCs in the sample is a determining factor in the outcome. LipAge Score Domain 3 (SVF preservation) has a direct clinical basis here.

2.3 Scar-Related Pain (7 studies, 276 patients)

Postmastectomy pain syndromeCaviggioli et al. 2011 (RCS, n=113): statistically significant pain reduction (VAS: 3.23 vs. 1.04). Maione et al. 2014 (n=88): confirmation of the effect. LEVEL OF EVIDENCE: II and III.
Painful and contractile scarsKlinger et al. 2013 (n=20): significant pain reduction on the POSAS scale after 12 months. Proposed mechanism: changes in the microenvironment through secretions from mesenchymal cells in the graft.
Vaginal/perineal scars after episiotomyUlrich et al. 2012 (n=20): significant reduction on the McGill Pain Questionnaire and VAS after 6 months.
Painful surgical scarsBaptista et al. 2013 (n=11): complete disappearance of pain in 27% of patients; reduced analgesic use in 72.7%.

2.4 Scar-Related Pruritus (3 studies, 44 patients)

Results varied — the mechanism of action on pruritus remains poorly understood. The evidence is insufficient for a definitive conclusion on this specific outcome.

03

Critical Limitations

⚠ Critical Analysis — Limitations Explicitly Acknowledged by the Authors

1. Predominantly low level of evidence: 14 of the 26 studies are level IV. Only 4 RCTs were included.

2. Small samples: most studies had n<50 patients. Meta-analysis was not possible because of heterogeneity.

3. Positive publication bias: the authors explicitly caution that all 26 studies reported positive results — which is not epidemiologically plausible without bias.

4. Short follow-up: 6 to 21 months in most studies. Long-term data (>2 years) are scarce.

5. Technical heterogeneity: AFG techniques varied (Coleman vs. non-Coleman), as did volumes — making it impossible to isolate the specific effect of AFG.

04

What Can and Cannot Be Said

✅A systematic review of 26 clinical studies involving 905 patients (Plast Reconstr Surg, 2016) documented a beneficial effect of autologous fat grafting on scar appearance, skin characteristics, pain, and pruritus.
✅Adding SVF to the autologous fat graft increases volume retention from 39% to 63% — supporting the relevance of preserving SVF in material cryopreserved by LipAge.
❌That material cryopreserved by LipAge produces the same outcomes as fresh material for these indications — no direct comparative data exist.
❌Assured clinical efficacy or gold-standard status — the review authors themselves stated that the evidence is still insufficient to support this conclusion.

Reviewed Article Details

TitleThe Use of Autologous Fat Grafting for Treatment of Scar Tissue and Scar-Related Conditions: A Systematic Review
AuthorsNegenborn VL, Groen J-W, Smit JM, Niessen FB, Mullender MG
JournalPlastic and Reconstructive Surgery — American Society of Plastic Surgeons
Year2016 — DOI: 10.1097/PRS.0000000000001850
N26 clinical studies · 905 patients
Relevance to LipAgeHigh — supports scars as a robust indication and demonstrates the role of SVF in volume retention